venous thromboembolism denise watt january 3, 2002
TRANSCRIPT
Venous Thromboembolism
Denise Watt
January 3, 2002
Outline
epidemiology pathophysiology risk factors diagnosis
• clinical• labs• diagnostic imaging• algorithms
treatment
Case 1
Rural ED 72 yo male fever, SOB, pleuritic CP x 2 days HR 110, bp 140/90, RR 22, sat 90% CXR unremarkable what test/Rx?
Case 2
55 yo man sudden central CP, SOB, presyncope HR 120, bp 90/70, RR 30, sats 88% ECG: sinus tach what tests/Rx?
Case 3
33 yo healthy woman, 34 wks GA syncope at home EMS called asystolic arrest en route CPR x 5 min what do you do?
Epidemiology
Lifetime incidence VTE 2-5%• PE: 0.5/1,000/year• DVT: 1/1,100/year
PE mortality:• 10% die in 1st hour• 30% untreated• 2-8% if anticoagulated
>50% PEs undiagnosed
Risk Factors
Primary• Factor V leiden• Antithrombin III
deficiency• Prot C deficiency• Prot S deficiency• hyperhomo-
cysteinemia• anticardiolipin Ab• dysfibrinogenemia
Secondary• age• trauma / surgery• malignancy• immobilization• stroke• smoking• obesity• OCP/HRT• lupus anticoagulant• pregnancy• hyperviscosity• heart failure
Risk Factors
50% without risk factors OCP/HRT: 3x baseline risk
• 0.3/10,000/yr; 15/10,000/yr• higher in 3rd gen progesterones
pregnancy: 5x baseline risk• 75% DVT antepartum, 66% PE
postpartum
Pathophysiology:Source of VTE
• most start in calf, extend proximally• 70% PE have DVT evidence at autopsy• 70-90% known source: IVC, ileofemoral
or pelvic veins, 10-20% SVC• incidence of PE from DVT
• calf: 46%• thigh: 67%• pelvic: 77%
• other: UE, jugular, mesenteric, cerebral
Consequences of PE
Hemodynamic• tachycardia• hypotension• RV overload and
dilation CVP LV preload myocardial flow • pulmonary HTN• pul A-V shunts
Respiratory• hyperventilation• PA HTN compliance• atelectasis• broncho-
constriction airway resistance
Clinical Presentation:DVT
Calf-popliteal• 80-90%, many asymptomatic• pain & swelling• spreads proximally
Ileofemoral• pain in buttock, groin• thigh swelling• 10-20% cases
Clinical Prediction Model for DVTWells et al. Ann Int Med, 1997
Score Active cancer 1 Paralysis,plaster immobilization
1
Immobilzation 1 Leg tenderness of deep veins
1
Entire leg swollen 1 Calf swelling >3cm 1 Pitting edema 1 Dilated superficial veins 1 Alternative diagnosis for DVT
-2
Clinical Model for DVT
Pre-test probability Score
High 3
Moderate 1 or 2
Low 0
Incidence of DVT by Clinical Probability
01020304050
60708090
100
Low Mod High Overall
Wells, 1997
Perrier, 1999
Clinical Presentation of PE:The great pretender
SOB, CP or tachypnea in 97% individual s+s not sensitive/specific peripheral (distal vessel)
• pleuritic CP, ± hemoptysis, ± SOBOE central (lobar / segmental)
• SOBOE massive (main pulmonary artery)
• syncope, hypotension, shock
Clinical Prediction Model for PEWells. Ann Int Med, 1998
Score Active cancer 1.0 Hemoptysis 1.0 Recent surgery 1.5 Previous VTE 1.5 HR > 100 1.5 Clinical signs DVT 3.0 No alternate diagnosis 3.0
Pre-test probability High 6 Moderate 2.5-5.5 Low 2
Incidence of PE by Clinical Probability
0
10
20
30
40
50
60
70
80
Low Mod High Overall
PIOPED, 1990
Wells, 1998
Perrier, 1999
Ancillary tests for PE
CXR:• r/o other diagnoses• ‘classic’ signs non-specific
ABG:• 20% have normal PaO2• 15-20% have normal Aa gradient
ECG: • remember???
D-dimer
degradation product of fibrin PPV poor; NPV excellent non-specific:
• +ve: surgery, trauma, hemorrhage, CA• 90% +ve >80 yrs old
most useful in ED patients NOT to r/o PE in high PTP
D-dimer AssaysVan der Graaf. Thromb Haemost, 2000.
Assay Ease of use
Sensitivity Specificity
Whole blood agglutination (SimpliRED)
++++ 80-85% 70-90%
Latex agglutination
+++ 90-95% 40-90%
Rapid ELISA ++++ 95-100% 30-60%
Diagnostic Imaging for DVT
Duplex / compression U/S• non-invasive, portable• direct visualization of veins and flow• loss of compression = DVT• 97% sensitive & specific for
symptomatic proximal/popliteal DVT• 62% sensitive for asymptomatic DVT• +ve in 30-50% PE; 5% non-dx V/Q scans
Serial Venous U/S
2 protocols: Wells & Hull may avoid angiography in ?PE 2% +ve in 2 weeks (?PE) if U/S -ve 2 weeks apart, <2% have
VTE in next 6 mos
Diagnostic Imaging for DVT
IPG• detects changes in flow before and after
cuff inflated• sensitivity 60%
Algorithm for Suspected first DVT:Perrier. Lancet, 1999
+trea t for D VT
LowD VT excluded
-D VT excluded
+trea t for D VT
Mod/H ighseria l U /S
-consider c linica l proba bility
+U /S
- D VT excluded
D -dim er
suspected D VT
Diagnostic Imaging for PE:V/Q scan
PIOPED: ventilation component adds little info
PISAPED criteria:• normal, non-diagnostic, high probability• 25%, 50%, 25% respectively• high prob: 85-90% PPV• non-diagnostic: 25% PE
interpret in context of PTP
Diagnostic Imaging for PE:Pulmonary Angiography
Gold standard (imperfect)• sens 98%, spec 95-98%
ED physicians reluctant to use:• invasive, risks, requires expertise, not
readily available, time consuming, $ relative contraindications indicated if non-invasive tests
inconclusive
Diagnostic Imaging for PE:Spiral CT
IV contrast, direct visualization subsegmental PE not well seen more specific, underlying lung dx sens depends on CT, experience wide variation in studies
• Rathbun. Ann Intern Med, 2000 (review)• sens 53-100%, spec 81-100%• poor methodolgy of studies
Spiral CT
Perrier. Ann Intern Med, 2001• sens 70%, spec 91% , 4% inconclusive• good interobserver agreement
CT venography:• benefit over U/S not determined
role? • no evidence to withold Rx if CT negative• may replace angiography
Diagnostic Imaging in PE:Echocardiography
useful for patients in shock/arrest • r/o DDx: tamponade, Ao dissection, AMI
indirect evidence of PE:• RV overload, septal shift to L, TR, PA
pressure, RV wall motion abn • sens 93%, spec 81%
‘sub-massive’ PE: independent predictor of mortality (?significance)
Algorithm for suspected PE:Wells. Ann Int Med, 2001
-PE exc luded
+
L owD -dim er
norm a lPE exc luded
L ow
PE exc luded
-
seria l U /S
+
M od D -dim er
seria l U /S
-
angiography
+
HighD -dim er
- D V Tcons ider PT P
+ D V T
non-diagnosticleg U/S
high probabi l i tytrea t for PE
V /Q
M od/HighD -dim er
PT P
Wells’ Algorithm:Criticism
Uses SimpliRED assay: lower sens. sCT not included
• could replace angiography? Low prevalence of PE (9%) not validated by other RCTs
Treatment of VTE:Goals
reduce mortality prevent extension/recurrence restore pulmonary vascular
resistance prevent pulmonary hypertension
Treatment of VTE:Anticoagulation
Out-patient LMWH LMWH superior to UFH? (Gould 1999)
out-pt Rx safe in PE (Kovacs, 2000)
DVT: start Rx, definitive test in 24hr baseline B/W
Anticoagulation
Enoxaparin 1mg/kg bid or 1.5 od Tinzaparin 175 anti-Xa u/kg od start warfarin 5mg on day 1 d/c LMWH when INR >2.0 x 2 days Rx 3 mos if 1st and reversible cause 6 mos if non-reversbile indefinite if recurrent, CA, genetic
Treatment of PE:Criteria for admission
Hemodynamic instability O2 requirement surgery < 48hr risk of active bleeding history of HIT IV pain control
Treatment of massive PE
judicious fluids (500cc max) NE, dopamine, dobutamine prn O2, intubate if shock
• positive pressure worsens RV fn anticoagulation
• if no contraindications• UFH if hypotensive• PTT 1.5-2.5 x normal
Treatment of massive PE:Thrombolytics
no evidence of mortality benefit• including in cardiac arrest (case series)
no benefit in hemodynamically stable improves pul. perfusion (15% vs 2%),
RV function (34% vs. 17%) cf. heparin t-PA faster hemodynamic effect IV same as intrapulmonary 5-10% major bleed, 1-2% ICH
Thrombolytics
2 week window of opportunity!• effect with time
no advantage of t-PA bolus protocols:
• t-PA: 100mg over 2 hr• UK: 4400U/kg over 10min; rpt x 12-24hr• SK: 250,000U over 30min; 100,000 x 24h• arrest: t-PA 10mg/kg bolus x 2 q 30 min
Embolectomy
Indicated in acute, massive PE if:• contraindication to thrombolytics• unresponsive to medical mgt
moribund pt poor results no evidence cf. with thrombolytics percutaneous vs. surgical
• ?role
IVC Filters
Indications:• contraindication to anticoagulation• recurrent VTE despite anticoagulation• after surgical embolectomy
no long term adv vs. anticoagulation anticoagulate if no contraindications
• DVT and IVC occlusion
Pregnancy
V/Q safe, no breastfeed x 15hr post D-dimer in pregnancy, wide Aa angiography safer than empiric Rx LMWH in DVT, not studied in PE PE: UFH IV x 4-5 days, then s/c treat x 3 months or 6 weeks postpartum switch to oral postpartum